 outcome childhood acute lymphoblastic leukaemia reinforced early treatment rotational combination chemotherapy outcome childhood acute lymphoblastic leukaemia ALL stratified study intensified chemotherapy evaluable patients remission reinforcement therapy teniposide cytarabine high-dose methotrexate four-drug induction regimen complete remission basis risk group assignment conventional continuation treatment pairs drugs weeks patients intrathecal chemotherapy higher-risk patients cGy cranial irradiation year remission Complete remission patients median follow-up months event-free survival SE overall lower-risk group higher-risk group Outcome risk groups speed rotation drug pairs continuation treatment Various high-risk subgroups responses treatment intensified chemotherapy children ALL